- Trials with a EudraCT protocol (2,313)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
2,313 result(s) found.
Displaying page 21 of 116.
| EudraCT Number: 2014-002282-30 | Sponsor Protocol Number: 2014-2 | Start Date*: 2014-07-30 |
| Sponsor Name:County council of Ostergotland | ||
| Full Title: Effects of oxygen treatment on mechanisms involved in ischemia-reperfusion injury: A pilot study in healthy volunteers. | ||
| Medical condition: Study performed in healthy male vonlunteers. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-000647-32 | Sponsor Protocol Number: PRIOTAB | Start Date*: 2014-10-22 |
| Sponsor Name:Karolinska University Hospital | ||
| Full Title: Investigation of the efficacy of degarelix as an acute treatment for patients with pedophilic disorder to reduce the risk for sexual child molestation: a prospective, randomized, double blind, and ... | ||
| Medical condition: Pedophilia acccording to DSM-5 (F65.4) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-004874-41 | Sponsor Protocol Number: NMDSG14A | Start Date*: 2016-07-25 |
| Sponsor Name:Nordic MDS study group | ||
| Full Title: Safety, Efficacy and Immune Response of Histamine Dihydrochloride and Low-dose Interleukin-2 in Chronic Myelomonocytic Leukemia (CMML) | ||
| Medical condition: Chronic myelomonocytic leukemia | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-004298-20 | Sponsor Protocol Number: MAMCAC02102014 | Start Date*: 2015-02-03 |
| Sponsor Name:Stockholm Centre for Dependency Disorders | ||
| Full Title: The effect of methylphenidate on executive functioning in amphetamine dependent individuals with ADHD | ||
| Medical condition: Amphetamine dependence | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-004829-82 | Sponsor Protocol Number: GHREDECIDE | Start Date*: 2019-04-16 |
| Sponsor Name:Linköping University | ||
| Full Title: Effects of the appetite-inducing hormone ghrelin on decision making in healthy volunteers | ||
| Medical condition: NA, healthy volunteers | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-001217-25 | Sponsor Protocol Number: 2016-001217-25 | Start Date*: 2016-09-07 |
| Sponsor Name:Uppsala University | ||
| Full Title: Emotion, Serotonin and Premenstrual Dysphoric Disorder (EmSeP) | ||
| Medical condition: Premenstrual Dysphoric Disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-004232-37 | Sponsor Protocol Number: Metylpred-01 | Start Date*: 2012-11-29 |
| Sponsor Name:Sahlgrenska Universtitetssjukhuset/SUS | ||
| Full Title: Prophylactic treatment with methylprednisolone may reduce the cerebral inflammatory response and reduce the severity of cognitive dysfunction after cardiac surgery | ||
| Medical condition: | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-003444-80 | Sponsor Protocol Number: 2020-01471 | Start Date*: 2020-11-17 |
| Sponsor Name:Sahlgrenska University Hospital | ||
| Full Title: Evaluation of the clinical implementation of biofilm susceptibility to antibiotics using Minimum Biofilm Eradication Concentration (MBEC) in addition to Minimum Inhibitory Concentration (MIC) to gu... | ||
| Medical condition: Periprosthetic hip or knee joint infections | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-005300-29 | Sponsor Protocol Number: SDF1 | Start Date*: 2016-06-06 |
| Sponsor Name:Malmö University, Faculty of Odontology | ||
| Full Title: Prevention and treatment of initial rotcaries among elderly in Skåne. | ||
| Medical condition: Dental caries | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-004780-71 | Sponsor Protocol Number: PROFERTIL | Start Date*: Information not available in EudraCT |
| Sponsor Name:Karolinska University Hospital | ||
| Full Title: A phase III Randomized Double-Blinded Placebo-Controlled Study of Use of GnRHa during Chemotherapy for Fertility Protection of Young Women and Teenagers with Cancer - ProFertil | ||
| Medical condition: Breast Cancer Acute Leukemia Lymphomas (Hodgkin and non-Hodgkin) Sarcomas (Osteo, Soft tissue and Ewing) | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults | Gender: Female | |
| Trial protocol: SE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-004132-22 | Sponsor Protocol Number: NPH-01 | Start Date*: 2021-01-20 | |||||||||||
| Sponsor Name:Uppsala University Hospital | |||||||||||||
| Full Title: Double-blind randomized acetazolamide trial in normal pressure hydrocephalus | |||||||||||||
| Medical condition: Normal pressure hydrocephalus | |||||||||||||
|
|||||||||||||
| Population Age: Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2019-001188-58 | Sponsor Protocol Number: IDIT001 | Start Date*: 2022-02-16 |
| Sponsor Name:Göteborgs Universitet | ||
| Full Title: The effect of anti-IL17 in new-onset type 1 diabetes: a randomized, double-blind, placebo-controlled trial | ||
| Medical condition: Type 1 diabetes | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-000244-10 | Sponsor Protocol Number: EGBAB | Start Date*: 2019-12-13 |
| Sponsor Name:Region Uppsala | ||
| Full Title: Influence of antibiotic treatment on the normal flora and the presence of resistance genes in known carriers of ESBL and VRE | ||
| Medical condition: Carriage of genes coding for vancomycin resistant enterococci (VRE) and extended spectrum betalactamase producing enterobacteriales (EPE) phenotypes. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-005860-69 | Sponsor Protocol Number: ODEN | Start Date*: 2021-05-10 |
| Sponsor Name:University of Gothenburg | ||
| Full Title: OSU6162 as add-on in SSRI/SNRI-resistant depression (ODEN): a double-blind, placebo-controlled evaluation of efficacy and safety. | ||
| Medical condition: Depression | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-004462-18 | Sponsor Protocol Number: ARDS-MSC-205 | Start Date*: 2020-06-02 | |||||||||||
| Sponsor Name:Uppsala University Hospital | |||||||||||||
| Full Title: MESENCHYMAL STROMAL CELL THERAPY FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME Validation of Mechanistic Pathways and Clinical Efficacy | |||||||||||||
| Medical condition: Acute respiratory distress syndrome (ARDS) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-000135-31 | Sponsor Protocol Number: TABENETOC | Start Date*: 2022-01-12 |
| Sponsor Name:Region Östergötland | ||
| Full Title: The Effect of tinzaparin on Biomarkers in FIGO Stage III-IV Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy – A randomized pilot study | ||
| Medical condition: Epithelial ovarian cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: SE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001980-95 | Sponsor Protocol Number: OBID | Start Date*: 2021-03-02 |
| Sponsor Name:University of Gothenburg | ||
| Full Title: OSU6162 in bipolar depression: an open-label, flexible dose study (OBID) | ||
| Medical condition: Depression Bipolar disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-005096-12 | Sponsor Protocol Number: OPRERA | Start Date*: 2021-05-31 | |||||||||||
| Sponsor Name:Karolinska Universitetssjukhuset | |||||||||||||
| Full Title: Utvärdering av två kortison behandlingsstrategier hos patienter med nydiagnostiserad, tidigare obehandlad reumatoid artrit: en randomiserad, öppen, non-inferiority klinisk studie | |||||||||||||
| Medical condition: Rheumatoid arthritis | |||||||||||||
|
|||||||||||||
| Population Age: | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-005738-13 | Sponsor Protocol Number: TPLBIS20 | Start Date*: 2021-02-16 |
| Sponsor Name:Region Skåne | ||
| Full Title: Pivmecillinam with Amoxicillin/clavulanic acid for Step Down Oral Therapy in Febrile UTIs Caused by ESBL-producing Enterobacterales. | ||
| Medical condition: Urinary tract infection and/or bacteremia caused by extended spectrum beta-lactamases-producing Enterobacterales | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-000492-39 | Sponsor Protocol Number: XIN-XSTEM-201 | Start Date*: 2022-07-05 | |||||||||||
| Sponsor Name:Xintela AB | |||||||||||||
| Full Title: A multi-centre, randomised, single-blind Phase I/IIa study to evaluate the safety, tolerability and efficacy of a single topical dose of allogeneic integrin α10β1-selected mesenchymal stem cells (X... | |||||||||||||
| Medical condition: Difficult-to-heal venous leg ulcers | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.